| Integrin type | Interacting ECM protein | Activated signaling cascade | Tumor/metastasis | Reference |
| α3β1 | Laminin | MMP9 and oncogenic Ras, VEGF, FAK-paxillin signaling cascade | Invasion in keratinocytes, Induces angiogenesis, Human hepatoma cells | [33, 34] | α6β1 | Laminin | Urokinase plasminogen activator and MMP-2, PI3Kinase, Src | Tumor invasion in pancreatic cells | [35, 36] | α7β1 | Laminin | Rho-A signaling cascade | Invasion in breast cancer | [37] | α2β1, α1β1, α10β1, αIIβ1 | Collagen | FAK and src signaling | Invasion of melanoma cells, cancer progression, and invasion of lung adenocarcinoma | [38, 39] | αvβ1, αvβ6, αvβ3 | Vitronectin, syndican, thromospondin-1 | MMP9, urokinase signaling, MEK/Erk/NF-B, PKCa, FAK | Metastatic breast Cancer, pancreatic, cervical, colon, lung/liver metastasis | [40–42] | α9β1 | CCN3, osteopontin | Src, P130 Cas, Rac, NOS signaling | Metastatic potential | [43] | αIIb3, αvb3 | Von Willebrand factor | Interacts with thrombospondin-1 and induces VEGF/FGF signaling | Breast cancer | [44, 45] | α5 | Fibronectin | FAK, ERK, PI-3 K, ILK, and nuclear factor-kappa B - | Metastatic lung and cervical cancer | [46, 47] | αLβ2 | Intercellular cell adhesion molecules | | Breast cancer | [1] |
|
|